President Donald Trump signs an enforcement bid aimed astatine reducing the outgo of medicine drugs and pharmaceuticals by 30% to 80% during an lawsuit successful the Roosevelt Room of the White House connected May 12, 2025, successful Washington, DC.
Andrew Harnik | Getty Images
Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump connected Friday to voluntarily merchantability their medications for less, arsenic his medication pushes to link the nation's cause prices to cheaper ones abroad.
That includes Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche's Genentech, privately-held Boehringer Ingelheim and Novartis.
That makes up the bulk of the 17 drugmakers Trump sent letters to successful July, calling connected them to little prices arsenic portion of his "most favored nation" policy. Trump signed an executive order successful May to revive that policy, calling for prices to beryllium accrued extracurricular of the U.S. and to "end planetary freeloading."
Trump said Johnson & Johnson is not present, "but volition beryllium present adjacent week."
Earlier this year, Trump announced agreements with Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca and EMD Serono to merchantability definite drugs straight to patients astatine a discount, successful speech for exemptions from his planned pharmaceutical tariffs and different benefits, specified arsenic fast-tracked reviews of caller drugs.
U.S. medicine cause prices connected mean are astir 3 times higher than overseas, according to a 2024 survey by RAND Corporation. Prices for branded drugs were much than 4 times higher, the study found.
Trump signed an executive order successful May to revive the astir favored federation policy, calling for prices to beryllium accrued extracurricular of the U.S. and to "end planetary freeloading."
Trade relation PhRMA, which represents galore large pharma companies, has said that most-favored federation pricing isn't the champion mode to little cause costs for Americans, and alternatively blamed pharmacy payment managers for the terms disparity.
The U.S. is the azygous astir important marketplace for galore drugmakers, careless of their location country. Despite being based crossed the Atlantic, European pharma companies are heavy exposed to the U.S. market, with fractional of the 10 largest companies connected the continent generating a majority of their income successful the U.S.
This is a breaking news story. Please refresh for updates.
English (US) ·